表紙
市場調查報告書
商品編碼
1028949

全球癌症臨床決策工具市場報告:2021年版 - COVID-19擴大和到2030年前的變化

Cancer Clinical Decision Tools Global Market Report 2021: COVID-19 Growth And Change To 2030

出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球癌症臨床決策工具市場相關調查,網羅市場特性,規模與成長,市場區隔,各地各國趨勢,競爭情形,市場佔有率,市場趨勢與策略。還有各地區的市場的實際成果與預測,及加入此市場的主要企業的簡介等資訊。

目錄

第1章 摘要整理

第2章 癌症臨床決策工具市場特徵

第3章 癌症臨床決策工具的市場趨勢與策略

第4章 COVID-19對癌症臨床決策工具帶來的影響

第5章 癌症臨床決策工具的市場規模與成長

  • 全球癌症臨床決策工具市場實際成果,2015∼2020年,10億美元
    • 市場促進因素
    • 市場阻礙因素
  • 全球癌症臨床決策工具市場預測,2020∼2025年,2030年,10億美元
    • 市場促進因素
    • 市場阻礙因素

第6章 癌症臨床決策工具市場細分化

  • 全球癌症臨床決策工具市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 風險評估工具(RAT)
  • Qcancer
  • 全球癌症臨床決策工具市場,各終端用戶市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 醫院
  • 診所

第7章 癌症臨床決策工具市場各地區以及各國分析

  • 全球癌症臨床決策工具市場,各地區,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 全球癌症臨床決策工具市場,各國,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第8章 亞太地區的癌症臨床決策工具市場

  • 亞太地區的癌症臨床決策工具市場概要
  • 地區資訊,COVID-19的影響,市場資訊,背景資訊,政府的積極推動,法規,法規機關,主要的協會,免稅,公司稅結構,投資,主要企業
  • 亞太地區的癌症臨床決策工具市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 亞太地區的癌症臨床決策工具市場,各終端用戶市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第9章 中國的癌症臨床決策工具市場

  • 中國的癌症臨床決策工具市場概要
  • 中國的癌症臨床決策工具市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 中國的癌症臨床決策工具市場,各終端用戶市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第10章 印度的癌症臨床決策工具市場

  • 印度的癌症臨床決策工具市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 印度的癌症臨床決策工具市場,各終端用戶市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第11章 日本的癌症臨床決策工具市場

  • 日本的癌症臨床決策工具市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 日本的癌症臨床決策工具市場,各終端用戶市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第12章 澳洲的癌症臨床決策工具市場

  • 澳洲的癌症臨床決策工具市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 澳洲的癌症臨床決策工具市場,各終端用戶市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第13章 印尼的癌症臨床決策工具市場

  • 印尼的癌症臨床決策工具市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 印尼的癌症臨床決策工具市場,各終端用戶市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第14章 韓國的癌症臨床決策工具市場

  • 韓國的癌症臨床決策工具市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 韓國的癌症臨床決策工具市場,各終端用戶市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第15章 西歐的癌症臨床決策工具市場

  • 西歐的癌症臨床決策工具市場概要
  • 西歐的癌症臨床決策工具市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 西歐的癌症臨床決策工具市場,各終端用戶市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第16章 英國的癌症臨床決策工具市場

  • 英國的癌症臨床決策工具市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 英國的癌症臨床決策工具市場,各終端用戶市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第17章 德國的癌症臨床決策工具市場

  • 德國的癌症臨床決策工具市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 德國的癌症臨床決策工具市場,各終端用戶市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第18章 法國的癌症臨床決策工具市場

  • 法國的癌症臨床決策工具市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 法國的癌症臨床決策工具市場,各終端用戶市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第19章 東歐的癌症臨床決策工具市場

  • 東歐的癌症臨床決策工具市場概要
  • 東歐的癌症臨床決策工具市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 東歐的癌症臨床決策工具市場,各終端用戶市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第20章 俄羅斯的癌症臨床決策工具市場

  • 俄羅斯的癌症臨床決策工具市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 俄羅斯的癌症臨床決策工具市場,各終端用戶市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第21章 北美的癌症臨床決策工具市場

  • 北美的癌症臨床決策工具市場概要
  • 北美的癌症臨床決策工具市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 北美的癌症臨床決策工具市場,各終端用戶市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第22章 美國的癌症臨床決策工具市場

  • 美國的癌症臨床決策工具市場概要
  • 美國的癌症臨床決策工具市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 美國的癌症臨床決策工具市場,各終端用戶市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第23章 南美的癌症臨床決策工具市場

  • 南美的癌症臨床決策工具市場概要
  • 南美的癌症臨床決策工具市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 南美的癌症臨床決策工具市場,各終端用戶市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第24章 巴西的癌症臨床決策工具市場

  • 巴西的癌症臨床決策工具市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 巴西的癌症臨床決策工具市場,各終端用戶市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第25章 中東的癌症臨床決策工具市場

  • 中東的癌症臨床決策工具市場概要
  • 中東的癌症臨床決策工具市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 中東癌症臨床決策工具市場,各終端用戶市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第26章 非洲的癌症臨床決策工具市場

  • 非洲的癌症臨床決策工具市場概要
  • 非洲的癌症臨床決策工具市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 非洲的癌症臨床決策工具市場,各終端用戶市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第27章 癌症臨床決策工具市場競爭情形和企業簡介

  • 癌症臨床決策工具市場競爭情形
  • 癌症臨床決策工具市場企業簡介
    • McKesson Corporation
    • Medical Information Technology Inc.
    • Philips Healthcare
    • Elsevier B.V.
    • Siemens Healthineers

第28章 癌症臨床決策工具市場上主要合併和收購

第29章 癌症臨床決策工具市場未來展望和潛在性分析

第30章 附錄

目錄
Product Code: h974

Cancer Clinical Decision Tools Global Market Report 2021: COVID-19 Growth And Change to 2030 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global cancer clinical decision tools market.

This report focuses on cancer clinical decision tools market which is experiencing strong growth. The report gives a guide to the cancer clinical decision tools market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the cancer clinical decision tools? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Cancer Clinical Decision Tools market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider cancer clinical decision tools market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The cancer clinical decision tools market section of the report gives context. It compares the cancer clinical decision tools market with other segments of the cancer clinical decision tools market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, cancer clinical decision tools indicators comparison.

Scope

Markets Covered:

1) By Type: Risk Assessment Tool(RAT); Qcancer

2) By End-User: Hospital; Clinics

Companies Mentioned: McKesson Corporation; Medical Information Technology Inc.; Philips Healthcare; Elsevier B.V.; Siemens Healthineers

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Cancer Clinical Decision Tools Market Characteristics

3. Cancer Clinical Decision Tools Market Trends And Strategies

4. Impact Of COVID-19 On Cancer Clinical Decision Tools

5. Cancer Clinical Decision Tools Market Size And Growth

  • 5.1. Global Cancer Clinical Decision Tools Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Cancer Clinical Decision Tools Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Cancer Clinical Decision Tools Market Segmentation

  • 6.1. Global Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Risk Assessment Tool(RAT)
  • Qcancer
  • 6.2. Global Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospital
  • Clinics

7. Cancer Clinical Decision Tools Market Regional And Country Analysis

  • 7.1. Global Cancer Clinical Decision Tools Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Cancer Clinical Decision Tools Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Cancer Clinical Decision Tools Market

  • 8.1. Asia-Pacific Cancer Clinical Decision Tools Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Cancer Clinical Decision Tools Market

  • 9.1. China Cancer Clinical Decision Tools Market Overview
  • 9.2. China Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Cancer Clinical Decision Tools Market

  • 10.1. India Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Cancer Clinical Decision Tools Market

  • 11.1. Japan Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Cancer Clinical Decision Tools Market

  • 12.1. Australia Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Cancer Clinical Decision Tools Market

  • 13.1. Indonesia Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Cancer Clinical Decision Tools Market

  • 14.1. South Korea Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Cancer Clinical Decision Tools Market

  • 15.1. Western Europe Cancer Clinical Decision Tools Market Overview
  • 15.2. Western Europe Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Cancer Clinical Decision Tools Market

  • 16.1. UK Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Cancer Clinical Decision Tools Market

  • 17.1. Germany Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Cancer Clinical Decision Tools Market

  • 18.4. France Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.5. France Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Cancer Clinical Decision Tools Market

  • 19.1. Eastern Europe Cancer Clinical Decision Tools Market Overview
  • 19.2. Eastern Europe Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Cancer Clinical Decision Tools Market

  • 20.1. Russia Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Cancer Clinical Decision Tools Market

  • 21.1. North America Cancer Clinical Decision Tools Market Overview
  • 21.2. North America Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Cancer Clinical Decision Tools Market

  • 22.1. USA Cancer Clinical Decision Tools Market Overview
  • 22.2. USA Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Cancer Clinical Decision Tools Market

  • 23.1. South America Cancer Clinical Decision Tools Market Overview
  • 23.2. South America Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Cancer Clinical Decision Tools Market

  • 24.1. Brazil Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Cancer Clinical Decision Tools Market

  • 25.1. Middle East Cancer Clinical Decision Tools Market Overview
  • 25.2. Middle East Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Cancer Clinical Decision Tools Market

  • 26.1. Africa Cancer Clinical Decision Tools Market Overview
  • 26.2. Africa Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Cancer Clinical Decision Tools Market Competitive Landscape And Company Profiles

  • 27.1. Cancer Clinical Decision Tools Market Competitive Landscape
  • 27.2. Cancer Clinical Decision Tools Market Company Profiles
    • 27.2.1. McKesson Corporation
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Medical Information Technology Inc.
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Philips Healthcare
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Elsevier B.V.
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Siemens Healthineers
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Cancer Clinical Decision Tools Market

29. Cancer Clinical Decision Tools Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Research Inquiries
  • 30.4. The Business Research Company
  • 30.5. Copyright And Disclaimer